BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36648694)

  • 21. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
    Malmgren JA; Mayer M; Atwood MK; Kaplan HG
    Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metastasis in de novo stage IV breast cancer.
    He Y; Shao Y; Chen Q; Liu C; Zhu F; Liu H
    Breast; 2023 Oct; 71():54-59. PubMed ID: 37499376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
    Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
    Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
    den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
    Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
    Müller V; Hein A; Hartkopf AD; Fasching PA; Kolberg HC; Hadji P; Tesch H; Häberle L; Ettl J; Lüftner D; Wallwiener M; Beckmann MW; Schneeweiss A; Belleville E; Uhrig S; Wimberger P; Hielscher C; Meyer J; Wurmthaler LA; Kurbacher CM; Wuerstlein R; Untch M; Janni W; Taran FA; Lux MP; Wallwiener D; Brucker SY; Fehm TN; Michel LL
    Eur J Cancer; 2022 Sep; 172():13-21. PubMed ID: 35728342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Difference in Prognostic Outcomes Between
    Yamamura J; Kamigaki S; Fujita J; Osato H; Komoike Y
    In Vivo; 2018; 32(2):353-358. PubMed ID: 29475920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
    Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
    Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
    Brandão M; Martins-Branco D; De Angelis C; Vuylsteke P; Gelber RD; Van Damme N; van Walle L; Ferreira AR; Lambertini M; Poggio F; Verhoeven D; Barbeaux A; Duhoux FP; Wildiers H; Caballero C; Awada A; Piccart-Gebhart M; Punie K; de Azambuja E
    Breast Cancer Res Treat; 2024 Jan; 203(2):351-363. PubMed ID: 37878152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands.
    Elferink MA; de Jong KP; Klaase JM; Siemerink EJ; de Wilt JH
    Int J Colorectal Dis; 2015 Feb; 30(2):205-12. PubMed ID: 25503801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trastuzumab and survival of patients with metastatic breast cancer.
    Kast K; Schoffer O; Link T; Forberger A; Petzold A; Niedostatek A; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
    Arch Gynecol Obstet; 2017 Aug; 296(2):303-312. PubMed ID: 28616827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Donskov F; Xie W; Overby A; Wells JC; Fraccon AP; Sacco CS; Porta C; Stukalin I; Lee JL; Koutsoukos K; Yuasa T; Davis ID; Pezaro C; Kanesvaran R; Bjarnason GA; Sim HW; Rathi N; Kollmannsberger CK; Canil CM; Choueiri TK; Heng DYC
    Eur Urol Oncol; 2020 Aug; 3(4):530-539. PubMed ID: 32037304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
    Shen T; Gao C; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of metachronous metastases after curative treatment of colorectal cancer.
    van Gestel YR; de Hingh IH; van Herk-Sukel MP; van Erning FN; Beerepoot LV; Wijsman JH; Slooter GD; Rutten HJ; Creemers GJ; Lemmens VE
    Cancer Epidemiol; 2014 Aug; 38(4):448-54. PubMed ID: 24841870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.
    Zeichner SB; Herna S; Mani A; Ambros T; Montero AJ; Mahtani RL; Ahn ER; Vogel CL
    Breast Cancer Res Treat; 2015 Oct; 153(3):617-24. PubMed ID: 26358708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
    Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer.
    Kitagawa D; Horiguchi S; Yamashita T; Kuroi K; Shimizu K
    J Nippon Med Sch; 2014; 81(3):139-47. PubMed ID: 24998960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study.
    Leone JP; Leone BA; Zwenger AO; Vallejo CT; Romero AO; Machiavelli MR; Pérez JE; Leone J
    Breast Cancer Res Treat; 2021 May; 187(1):237-244. PubMed ID: 33389398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.